Publications search

Found 37769 matches. Displaying 2371-2380
Rationale Cocaine addiction is a chronic brain disease characterized by compulsive drug intake and dysregulation of brain reward systems. Few preclinical studies have modeled the natural longitudinal course of cocaine addiction. Extended access self-administration protocols are powerful tools for modeling the advanced stages of addiction; however, few studies have duration of drug access longer than 12 h/session, potentially limiting their construct validity. Identification of changes in cocaine intake patterns during the development of addictive-like states may allow better treatments for vulnerable subjects. The kappa opioid receptor (KOPr) system has been implicated in the neurobiological regulation of addictive states as well as mood and stress disorders, with selective KOPr antagonists proposed as possible pharmacotherapeutic agents. Chronic cocaine exposure increases the expression of KOPr and its endogenous agonists, the dynorphins, in several brain areas in rodents. Objectives To examine the behavioral pattern of intake during chronic (14 days) 18 h intravenous cocaine self-administration (0.5 mg/kg/infusion) and the effect of a novel short-acting KOPr antagonist LY2444296 HCl (3 mg/kg) administered during sessions 8 to 14 of chronic 18 h/day cocaine self-administration and prior to a single re-exposure session after 2 cocaine-free withdrawal days. Results Both daily and hourly cocaine intake patterns changed over 14 days of 18 h self-administration. LY pretreatment affected the pattern of self-administration across the second week of extended access cocaine self-administration and prevented the increase in cocaine intake during re-exposure. Conclusions Overall, the KOPr antagonist attenuated escalated cocaine consumption in a rat model of extended access cocaine self-administration.
Zhang ZD, Zhou CL, Li XL, Barnes SD, Deng S, Hoover E, Chen CC, Lee YS, Zhang YX, Wang CS, Metang LA, Wu C, Tirado CR, Johnson NA, Wongvipat J, Navrazhina K, Cao Z, Choi D, Huang CH, Linton E, Chen XP, Liang YP, Mason CE, de Stanchina E, Abida W, Lujambio A, Li S, Lowe SW, Mendell JT, Malladi VS, Sawyers CL, Mu P
Show All Authors

Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation

CANCER CELL 2020 APR 13; 37(4):584-598.e11
Metastatic prostate cancer is characterized by recurrent genomic copy number alterations that are presumed to contribute to resistance to hormone therapy. We identified CHD1 loss as a cause of antiandrogen resistance in an in vivo small hairpin RNA (shRNA) screen of 730 genes deleted in prostate cancer. ATAC-seq and RNA-seq analyses showed that CHD1 loss resulted in global changes in open and closed chromatin with associated transcriptomic changes. Integrative analysis of this data, together with CRISPR-based functional screening, identified four transcription factors (NR3C1, POU3F2, NR2F1, and TBX2) that contribute to antiandrogen resistance, with associated activation of non-luminal lineage programs. Thus, CHD1 loss results in chromatin dysregulation, thereby establishing a state of transcriptional plasticity that enables the emergence of antiandrogen resistance through heterogeneous mechanisms.
Oksenhendler E, Spaan AN, Neven B, Stolzenberg MC, Fusaro M, Casanova JL, Rieux-Laucat F, Boisson B, Mag?rus A
Show All Authors

Autoimmune Lymphoproliferative Syndrome Presenting with Invasive Streptococcus pneumoniae Infection

JOURNAL OF CLINICAL IMMUNOLOGY 2020 APR; 40(3):543-546
Frew JW
Show All Authors

Putting nodule counts behind us: hidradenitis suppurativa outcome measures independent of descriptive semantics

BRITISH JOURNAL OF DERMATOLOGY 2020 APR; 182(4):829-830
Abt I, Adamczyk L, Aggarwal R, Aushev V, Behnke O, Behrens U, Bertolin A, Bloch I, Brock I, Brook NH, Brugnera R, Bruni A, Bussey PJ, Caldwell A, Capua M, Catterall CD, Chwastowski J, Ciborowski J, Ciesielski R, Cooper-Sarkar AM, Corradi M, Dementiev RK, Dusini S, Ferrando J, Floerchinger S, Foster B, Gallo E, Gangadharan D, Garfagnini A, Geiser A, Gladilin LK, Golubkov YA, Grzelak G, Gwenlan C, Hochman D, Jomhari NZ, Kadenko I, Kananov S, Karshon U, Kaur P, Klanner R, Klein U, Korzhavina IA, Kovalchuk N, Kowalski H, Kuprash O, Kuze M, Levchenko BB, Levy A, Lohr B, Lohrmann E, Longhin A, Lukina OY, Makarenko I, Malka J, Masciocchi S, Nagano K, Nam JD, Onderwaater J, Onishchuk Y, Paul E, Pidhurskyi I, Polini A, Przybycien M, Quintero A, Ruspa M, Saxon DH, Schneekloth U, Schorner-Sadenius T, Selyuzhenkov I, Shchedrolosiev M, Shcheglova LM, Skillicorn IO, Slominski W, Solano A, Stanco L, Stefaniuk N, Stopa P, Surrow B, Sztuk-Dambietz J, Tassi E, Tokushuku K, Turcato M, Turkot O, Tymieniecka T, Verbytskyi A, Abdullah WATW, Wichmann K, Wing M, Yamada S, Yamazaki Y, Zarnecki AF, Zawiejski L, Zenaiev O
Show All Authors

Two-particle azimuthal correlations as a probe of collective behaviour in deep inelastic ep scattering at HERA

JOURNAL OF HIGH ENERGY PHYSICS 2020 APR 14; ?(4):? Article 070
Two-particle azimuthal correlations have been measured in neutral current deep inelastic ep scattering with virtuality Q(2)> 5 GeV2 at a centre-of-mass energy root s = 318 GeV recorded with the ZEUS detector at HERA. The correlations of charged particles have been measured in the range of laboratory pseudorapidity -1.5 < eta < 2.0 and transverse momentum 0.1 < p(T)< 5.0 GeV and event multiplicities N-ch up to six times larger than the average < N-ch >approximate to 5. The two-particle correlations have been measured in terms of the angular observables c(n{2})=<< cosn Delta phi >>, where n is between 1 and 4 and phi is the relative azimuthal angle between the two particles. Comparisons with available models of deep inelastic scattering, which are tuned to reproduce inclusive particle production, suggest that the measured two-particle correlations are dominated by contributions from multijet production. The correlations observed here do not indicate the kind of collective behaviour recently observed at the highest RHIC and LHC energies in high-multiplicity hadronic collisions.
Thi VLD, Wu XF, Belote RL, Andreo U, Takacs CN, Fernandez JP, Vale-Silva LA, Prallet S, Decker CC, Fu RM, Qu BQ, Uryu K, Molina H, Saeed M, Steinmann E, Urban S, Singaraja RR, Schneider WM, Simon SM, Rice CM
Show All Authors

Stem cell-derived polarized hepatocytes

NATURE COMMUNICATIONS 2020 APR 3; 11(1):? Article 1677
Human stem cell-derived hepatocyte-like cells (HLCs) offer an attractive platform to study liver biology. Despite their numerous advantages, HLCs lack critical in vivo characteristics, including cell polarity. Here, we report a stem cell differentiation protocol that uses trans-well filters to generate columnar polarized HLCs with clearly defined basolateral and apical membranes separated by tight junctions. We show that polarized HLCs secrete cargo directionally: Albumin, urea, and lipoproteins are secreted basolaterally, whereas bile acids are secreted apically. Further, we show that enterically transmitted hepatitis E virus (HEV) progeny particles are secreted basolaterally as quasi-enveloped particles and apically as naked virions, recapitulating essential steps of the natural infectious cycle in vivo. We also provide proof-of-concept that polarized HLCs can be used for pharmacokinetic and drug-drug interaction studies. This novel system provides a powerful tool to study hepatocyte biology, disease mechanisms, genetic variation, and drug metabolism in a more physiologically relevant setting.
Hsieh A, Morton SU, Willcox JAL, Gorham JM, Tai AC, Qi HJ, DePalma S, McKean D, Griffin E, Manheimer KB, Bernstein D, Kim RW, Newburger JW, Porter GA, Srivastava D, Tristani-Firouzi M, Brueckner M, Lifton RP, Goldmuntz E, Gelb BD, Chung WK, Seidman CE, Seidman JG, Shen YF
Show All Authors

EM-mosaic detects mosaic point mutations that contribute to congenital heart disease

GENOME MEDICINE 2020 APR 29; 12(1):? Article 42
Background The contribution of somatic mosaicism, or genetic mutations arising after oocyte fertilization, to congenital heart disease (CHD) is not well understood. Further, the relationship between mosaicism in blood and cardiovascular tissue has not been determined. Methods We developed a new computational method, EM-mosaic (Expectation-Maximization-based detection of mosaicism), to analyze mosaicism in exome sequences derived primarily from blood DNA of 2530 CHD proband-parent trios. To optimize this method, we measured mosaic detection power as a function of sequencing depth. In parallel, we analyzed our cohort using MosaicHunter, a Bayesian genotyping algorithm-based mosaic detection tool, and compared the two methods. The accuracy of these mosaic variant detection algorithms was assessed using an independent resequencing method. We then applied both methods to detect mosaicism in cardiac tissue-derived exome sequences of 66 participants for which matched blood and heart tissue was available. Results EM-mosaic detected 326 mosaic mutations in blood and/or cardiac tissue DNA. Of the 309 detected in blood DNA, 85/97 (88%) tested were independently confirmed, while 7/17 (41%) candidates of 17 detected in cardiac tissue were confirmed. MosaicHunter detected an additional 64 mosaics, of which 23/46 (50%) among 58 candidates from blood and 4/6 (67%) of 6 candidates from cardiac tissue confirmed. Twenty-five mosaic variants altered CHD-risk genes, affecting 1% of our cohort. Of these 25, 22/22 candidates tested were confirmed. Variants predicted as damaging had higher variant allele fraction than benign variants, suggesting a role in CHD. The estimated true frequency of mosaic variants above 10% mosaicism was 0.14/person in blood and 0.21/person in cardiac tissue. Analysis of 66 individuals with matched cardiac tissue available revealed both tissue-specific and shared mosaicism, with shared mosaics generally having higher allele fraction. Conclusions We estimate that similar to 1% of CHD probands have a mosaic variant detectable in blood that could contribute to cardiac malformations, particularly those damaging variants with relatively higher allele fraction. Although blood is a readily available DNA source, cardiac tissues analyzed contributed similar to 5% of somatic mosaic variants identified, indicating the value of tissue mosaicism analyses.
Jamee M, Mahdaviani SA, Mansouri D, Azizi G, Joneidi N, Ghaffaripour H, Eskandarzade S, Ghaini M, Marjani M, Moniri A, Migaud M, Casanova J, Puel A, Velayati A
Show All Authors

Delay in the Diagnosis of APECED: A Case Report and Review of Literature from Iran

IMMUNOLOGICAL INVESTIGATIONS 2020 APR 2; 49(3):299-306
Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) syndrome is a rare monogenic autosomal recessive disorder caused by biallelic mutations in the AIRE (autoimmune regulator) gene. Patients with APECED present with heterogeneous endocrine and non-endocrine manifestations. In this study, we report an Iranian patient who presented with Addison disease, chronic mucocutaneous candidiasis, alopecia totalis, keratopathy and asplenia treated as an isolated endocrinopathy for 25 years. In the adulthood, the diagnosis of APECED was made by genetic analysis which demonstrated homozygous nonsense p.R257* (c.769C>T) mutation of AIRE. APECED has been shown to be frequent in some ethnicities including Iranian Jews. Therefore, we reviewed 39 Iranian APECED patients published in the literature. We found that most of the Iranian patients were of Jewish ethnic background and presented hypoparathyroidism, adrenal insufficiency, and candidiasis as the main clinical manifestation.
Blancas-Galicia L, Santos-Chavez E, Deswarte C, Mignac Q, Medina-Vera I, Leon-Lara X, Roynard M, Scheffler-Mendoza SC, Rioja-Valencia R, Alvirde-Ayala A, Reyes SOL, Staines-Boone T, Garcia-Campos J, Saucedo-Ramirez OJ, Navarro BEDR, Zamora-Chavez A, Lopez-Larios A, Garcia-Pavon-Osorio S, Melgoza-Arcos E, Canseco-Raymundo MR, Mogica-Martinez D, Venancio-Hernandez M, Pacheco-Rosas D, Pedraza-Sanchez S, Guevara-Cruz M, Saracho-Weber F, Gamez-Gonzalez B, Wakida-Kuzunoki G, Moran-Mendoza AR, Macias-Robles AP, Ramirez-Rivera R, Vargas-Camano E, Zarate-Hernandez C, Gomez-Tello H, Ramirez-Sanchez E, Ruiz-Hernandez F, Ramos-Lopez D, Acuna-Martinez H, Garcia-Cruz ML, Roman-Jimenez MG, Gonzalez-Villarreal MG, Alvarez-Cardona A, Llamas-Guillen BA, Cuellar-Rodriguez J, Olaya-Vargas A, Ramirez-Uribe N, Boisson-Dupuis S, Casanova JL, Espinosa-Rosales FJ, Serafin-Lopez J, Yamazaki-Nakashimada M, Espinosa-Padilla S, Bustamante J
Show All Authors

Genetic, Immunological, and Clinical Features of the First Mexican Cohort of Patients with Chronic Granulomatous Disease

JOURNAL OF CLINICAL IMMUNOLOGY 2020 APR; 40(3):475-493
Purpose Chronic granulomatous disease (CGD) is a primary immunodeficiency characterized by an inability of phagocytes to produce reactive oxygen species, impairing their killing of various bacteria and fungi. We summarize here the 93 cases of CGD diagnosed in Mexico from 2011 to 2019. Methods Thirteen Mexican hospitals participated in this study. We describe the genetic, immunological, and clinical features of the 93 CGD patients from 78 unrelated kindreds. Results Eighty-two of the patients (88%) were male. All patients developed bacterial infections and 30% suffered from some kind of fungal infection. Fifty-four BCG-vaccinated patients (58%) presented infectious complications of BCG vaccine. Tuberculosis occurred in 29%. Granulomas were found in 56% of the patients. Autoimmune and inflammatory diseases were present in 15% of patients. A biological diagnosis of CGD was made in 89/93 patients, on the basis of NBT assay (n = 6), DHR (n = 27), and NBT plus DHR (n = 56). The deficiency was complete in all patients. The median age of biological diagnosis was 17 months (range, 0-186 months). A genetic diagnosis was made in 83/93 patients (when material was available), corresponding to CYBB (n = 64), NCF1 (n = 7), NCF2 (n = 7), and CYBA (n = 5) mutations. Conclusions The clinical manifestations in these Mexican CGD patients were similar to those in patients elsewhere. This cohort is the largest in Latin America. Mycobacterial infections are an important cause of morbidity in Mexico, as in other countries in which tuberculosis is endemic and infants are vaccinated with BCG. X-linked CGD accounted for most of the cases in Mexico, as in other Latin American countries. However, a significant number of CYBA and NCF2 mutations were identified, expanding the spectrum of known causal mutations.
Fitzgerald D, Laurent M, Funaro M, Harel A, DeAngelis T, Bangeranye C, Najjar S, Tabansky I, Stern JNH
Show All Authors

Defining the Role of T Lymphocytes in the Immunopathogenesis of Neuromyelitis Optica Spectrum Disorder

DISCOVERY MEDICINE 2020 APR; 29(157):91-102
Auto-reactive T cells are fundamental to many autoimmune processes, including neuromyelitis optica spectrum disorder (NMOSD). Several lines of evidence indicate that an antibody against aquaporin-4 (AQP4) is present in NMOSD patients. Further, this AQP4 antibody is pathogenic and can cause profound neurological damage. T cells are fundamental to many autoimmune processes, including NMOSD. Here we review work from animal models to discuss mechanisms by which auto-reactive T cells modulate the process by which antibodies cross the blood-brain barrier and orchestrate the local inflammatory milieu underlying NMOSD pathophysiology. We also examine clinical studies that document the presence of AQP4-specific T cells and the unique cytokine profile of NMOSD patients. This work encourages a renewed and broadened attention to the fundamental role of T cells in neuroautoimmune conditions which will hopefully lead to new therapies and better patients' outcomes.